ES2153113T3 - Compuestos de benzotiofeno. - Google Patents

Compuestos de benzotiofeno.

Info

Publication number
ES2153113T3
ES2153113T3 ES96922500T ES96922500T ES2153113T3 ES 2153113 T3 ES2153113 T3 ES 2153113T3 ES 96922500 T ES96922500 T ES 96922500T ES 96922500 T ES96922500 T ES 96922500T ES 2153113 T3 ES2153113 T3 ES 2153113T3
Authority
ES
Spain
Prior art keywords
compounds
benzotiophene
acrylic
directed
propionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96922500T
Other languages
English (en)
Inventor
Charles D Jones
Alan D Palkowitz
Kenneth J Thrasher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2153113T3 publication Critical patent/ES2153113T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms

Abstract

ESTA INVENCION ESTA DIRIGIDA A UNA CLASE DE COMPUESTOS DE ACIDO ACRILICO Y PROPIONICO Y SU USO EN EL TRATAMIENTO DE SINTOMAS POST LA INVENCION ESTA DIRIGIDA A INTERMEDIOS Y PROCEDIMIENTOS PARA LA PREPARACION DE LOS COMPUESTOS DE ACIDO ACRILICO Y PROPIONICO.
ES96922500T 1995-06-26 1996-06-25 Compuestos de benzotiofeno. Expired - Lifetime ES2153113T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52095P 1995-06-26 1995-06-26

Publications (1)

Publication Number Publication Date
ES2153113T3 true ES2153113T3 (es) 2001-02-16

Family

ID=21691867

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96922500T Expired - Lifetime ES2153113T3 (es) 1995-06-26 1996-06-25 Compuestos de benzotiofeno.

Country Status (12)

Country Link
US (1) US6440958B1 (es)
EP (1) EP0842169B1 (es)
JP (1) JPH11508269A (es)
AT (1) ATE198477T1 (es)
AU (1) AU6335496A (es)
CA (1) CA2220991A1 (es)
DE (1) DE69611452T2 (es)
DK (1) DK0842169T3 (es)
ES (1) ES2153113T3 (es)
GR (1) GR3035492T3 (es)
PT (1) PT842169E (es)
WO (1) WO1997001549A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827876A (en) * 1996-04-09 1998-10-27 American Home Products Corporation Inhibition of bone loss by 3-(4-acrylamidobenzoyl) benzo b!-thiophenes
WO1998049161A1 (en) * 1997-04-30 1998-11-05 Eli Lilly And Company Antithrombotic agents
US6090843A (en) * 1997-08-11 2000-07-18 Eli Lilly And Company Benzothiophenes compounds which have useful pharmaceutical activity
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN
US6096781A (en) * 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
US6087378A (en) * 1998-10-13 2000-07-11 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
FR2813307B1 (fr) * 2000-08-23 2002-11-08 Sanofi Synthelabo Aminoalkenylbenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
JP2004531559A (ja) * 2001-05-22 2004-10-14 イーライ・リリー・アンド・カンパニー エストロゲン欠乏または内因性エストロゲンに対する異常な生理反応に関連する疾患を抑制するためのテトラヒドロキノリン誘導体
US7056931B2 (en) 2001-05-22 2006-06-06 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
US7306283B2 (en) 2002-11-21 2007-12-11 W.E.T. Automotive Systems Ag Heater for an automotive vehicle and method of forming same
WO2011149680A1 (en) 2010-05-27 2011-12-01 W.E.T. Automotive Systems, Ltd. Heater for an automotive vehicle and method of forming same
US9191997B2 (en) 2010-10-19 2015-11-17 Gentherm Gmbh Electrical conductor
DE102012000977A1 (de) 2011-04-06 2012-10-11 W.E.T. Automotive Systems Ag Heizeinrichtung für komplex geformte Oberflächen
US10201039B2 (en) 2012-01-20 2019-02-05 Gentherm Gmbh Felt heater and method of making
DE102012017047A1 (de) 2012-08-29 2014-03-06 W.E.T. Automotive Systems Ag Elektrische Heizeinrichtung
DE102012024903A1 (de) 2012-12-20 2014-06-26 W.E.T. Automotive Systems Ag Flächengebilde mit elektrischen Funktionselementen
CU24337B1 (es) 2013-02-19 2018-04-03 Novartis Ag Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógenos

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274213A (en) 1961-09-05 1966-09-20 Upjohn Co Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes
US3396169A (en) 1966-10-26 1968-08-06 Upjohn Co Substituted 2-phenyl-1-(tertiary-aminoalkoxy) phenyl-3, 4-dihydronaphthalenes
US3862232A (en) 1963-07-03 1975-01-21 Upjohn Co 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof
US3313853A (en) 1963-10-16 1967-04-11 Upjohn Co 2-(tertiaryaminoalkoxyphenyl)-3, 4-dihydronaphthalenes and 2-(tertiaryaminoalkoxyphenyl) -3, 4- dihydro -1(2h)-naphthalenones
US3293263A (en) 1963-12-09 1966-12-20 Upjohn Co Diphenylbenzocycloalkenes
US3320271A (en) 1964-06-01 1967-05-16 Upjohn Co 1, 2-diphenyl-3, 4-dihydronaphthalenes and 2, 3-diphenylindenes
GB1138163A (en) 1965-05-21 1968-12-27 Bristol Myers Co Benzothiophene derivatives having anti-fertility properties
US3394125A (en) 1965-10-23 1968-07-23 Bristol Myers Co 2-phenyl-3-tertiary-aminoalkoxy phenyl-and corresponding tertiaryaminoalkyl thio benzfurans substituted in the benzo nucleus with an alkoxy or tertiaryamino alkoxy or alkylthio group
US3483293A (en) 1967-12-15 1969-12-09 Upjohn Co Method for controlling birds and rodents
US3567737A (en) 1968-01-02 1971-03-02 Upjohn Co Derivatives of (2-cycloalkyl-1-phenyl-3,4-dihydronaphthalenes and) 2 - cycloalkyl - 1 - phenyl - 1,2,3,4 - tetrahydro-naphthalenes
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4230862A (en) 1975-10-28 1980-10-28 Eli Lilly And Company Antifertility compounds
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
GB8311678D0 (en) 1983-04-28 1983-06-02 Ici Plc Phenol derivatives
US5395842A (en) 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5254568A (en) 1990-08-09 1993-10-19 Council Of Scientific & Industrial Research Benzopyrans as antiestrogenic agents
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
US5480904A (en) * 1993-10-28 1996-01-02 Eli Lilly And Company Methods for inhibiting uterine fibrosis
US5532382A (en) * 1995-03-13 1996-07-02 Eli Lilly And Company Benzothiophenes substituted at the 3-carbonyl
US5514704A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophenes to inhibit leukotrienes
JP4111352B2 (ja) 1996-05-21 2008-07-02 新日鐵住金ステンレス株式会社 ステンレス鋼の高清浄化精錬法

Also Published As

Publication number Publication date
AU6335496A (en) 1997-01-30
ATE198477T1 (de) 2001-01-15
EP0842169B1 (en) 2001-01-03
DE69611452D1 (de) 2001-02-08
EP0842169A1 (en) 1998-05-20
WO1997001549A1 (en) 1997-01-16
US6440958B1 (en) 2002-08-27
JPH11508269A (ja) 1999-07-21
GR3035492T3 (en) 2001-05-31
EP0842169A4 (en) 1998-10-14
PT842169E (pt) 2001-04-30
DK0842169T3 (da) 2001-01-29
DE69611452T2 (de) 2001-06-13
CA2220991A1 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
ES2153113T3 (es) Compuestos de benzotiofeno.
EE9700267A (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
TR199902538T2 (xx) Yeni bile�imler.
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
DE69634900D1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
BG107537A (en) Method for the inhibition of human tnf alpha activity and its application
NO965378D0 (no) Pyrazolo- og pyrolopyridiner
TR199800815A2 (en) S�lfonilaminokarbonasitler.
DE69634951D1 (de) Topische verwendung von betulinsäure zur behandlung bösartiger melanome
SE9502893D0 (sv) Användning av kollagenas
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
GB2380939B (en) Treatment or prevention of auto-immune diseases
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69611598D1 (de) Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
ES2124990T3 (es) Conversion de bisnoralcohol en bisnoraldehido.
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
NO990450D0 (no) Behandling av sinnslidelser
DE69623325D1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
WO1989005644A3 (fr) Thienotricyclene
ITTO930806A0 (it) Purificazione dell' 1,1-dicloro-1-fluoroetano.
ID26405A (id) Pemurnian karboksaldehida
FR2769013B1 (fr) Traitement des boues de curage

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 842169

Country of ref document: ES